Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine

NCT02294474 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

505

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: SAR342434
DRUG: Humalog
DRUG: insulin glargine HOE901

Sponsor

Sanofi